Alogliptin And Metformin Hydrochloride Tablet, Film Coated
Product Images NDC 50090-5993

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Alogliptin And Metformin Hydrochloride (NDC 50090-5993). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Alogliptin 01)

FDA Label Image

Chemical Structure (Alogliptin 02)

FDA Label Image

Figure 1 (Alogliptin 03)

FDA Label Image

Figure 2 (Alogliptin 04)

FDA Label Image

Figure 3 (Alogliptin 05)

Figure 3 (Alogliptin 05)
The text appears to be a table showing the mean baseline of a study population using placebo, metformin, alogliptin, and a combination of alogliptin with metformin. The intent-to-treat population was used in the study. The text includes some numerical data and mentions significant differences between certain treatments.*
FDA Label Image

Figure 4 (Alogliptin 06)

FDA Label Image

Label Image (Lbl500905993)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.